Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Dasatinib-induced Hypopigmentation in pediatric patient with chronic myeloid leukemia: A Case Report and review of the literature

Case Report Dermatol Med, July 2018 
Alharbi B et al. 

Prognostic discrimination based on the EUTOS long term survival score within the international registry for chronic myeloid leukemia in children and adolescents (Millot F et al. Haematologica, August 2017)

Haematologica, August 2017 
Millot F et al

The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy (Samis J et al. Pediatr Blood Cancer, July 2017)

Pediatr Blood Cancer, July 2017 
Samis J et al

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

Leukemia, June 2018 
Suttorp M et al. 

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia (Ernst T et al. Leukemia, June 2018)

Leukemia, June 2018 
Ernst T et al. 

  1. Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents (Millot F et al. Cancer, May 2017)
  2. Death within 1 month of diagnosis in childhood cancer: an analysis of risk factors and scope of the problem (Green A et al. J Clin Oncol, March 2017)
  3. Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic-phase chronic myeloid leukemia treated with imatinib (Shima H et al. Pediatr Blood Cancer, February 2017)
  4. Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukemia with bone marrow fibrosis (Hussein K et al. Leukemia, February 2017)